In a few decades, gene-editing technologies could reduce the likelihood of common human diseases. Societies must use this ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...

Genome editing with CRISPR-Cas is often associated with the induction of mutations. However, a team of researchers from the ...

MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025NHP Proof-of-Concept Anticipated for Secreted Protein ...

We are excited to welcome Eric to our Board of Directors,” said Brian C. Thomas, PhD, CEO and founder of Metagenomi. “His tremendous track record in the pharmaceutical industry as well as his ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Informatics is a huge part of that workflow and we’ll continue to invest in software innovation to drive the most powerful insights available. In 2025, population-scale genome studies will begin ...

The de-extinction company led by CEO Ben Lamm has raked in $435 million in funding since its launch. He believes it has ...

In BlueAllele Corp. v. Intellia Therapeutics, Inc., 2024 U.S. Dist. Lexis 222094 (D. Del. Dec. 9, 2024)1, the District of ...

Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...